Mechanistic View of Risk Factors for Venous Thromboembolism
- 1 March 2012
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 32 (3), 563-568
- https://doi.org/10.1161/atvbaha.111.242818
Abstract
Venous thromboembolism is an episodic disease with an annual incidence of 2 to 3/1000 per year that is associated with a high morbidity and mortality. Risk factors for venous thromboembolism come in many guises. They fit into an extended version of Virchow's triad and they tilt the hemostatic balance toward clot formation. This can be achieved by decreasing blood flow and lowering oxygen tension, by activating the endothelium, by activating innate or acquired immune responses, by activating blood platelets, or by increasing the number of platelets and red blood cells or modifying the concentrations of pro- and anticoagulant proteins in the blood. In this narrative review we will discuss the known common risk factors within this pathophysiological framework.Keywords
This publication has 73 references indexed in Scilit:
- Relevance of the JAK2V617F mutation in patients with deep vein thrombosis of the legAnnals of Hematology, 2011
- Extracellular DNA traps promote thrombosisProceedings of the National Academy of Sciences of the United States of America, 2010
- Increased microparticle tissue factor activity in cancer patients with Venous ThromboembolismThrombosis Research, 2010
- A Follow-Up Study of a Genome-wide Association Scan Identifies a Susceptibility Locus for Venous Thrombosis on Chromosome 6p24.1American Journal of Human Genetics, 2010
- Platelet Polyphosphates Are Proinflammatory and Procoagulant Mediators In VivoCell, 2009
- Cancer cell–derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivoThe Journal of Experimental Medicine, 2009
- Thrombomodulin Mutations in Atypical Hemolytic–Uremic SyndromeThe New England Journal of Medicine, 2009
- Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulationProceedings of the National Academy of Sciences of the United States of America, 2007
- Microparticle‐associated tissue factor activity: a link between cancer and thrombosis?Journal of Thrombosis and Haemostasis, 2007
- Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenecity of human plateletsThe Journal of Experimental Medicine, 2006